Role of concomitant resistance in the development of murine lung metastases
- PMID: 3346106
- DOI: 10.1002/ijc.2910410317
Role of concomitant resistance in the development of murine lung metastases
Abstract
An attempt was made to explain the distinct lung metastatic patterns of 2 mammary adenocarcinomas with a common BALB/c origin: M3, which does not induce spontaneous metastases, and MM3 with an almost 100% incidence. No difference between the 2 tumors was detected with respect to host mononuclear cell content, degree of immunogenicity or lung-colony-forming ability. Conversely, there was a marked difference in the capacity to induce concomitant resistance: M3-bearing mice induced stronger and earlier resistance against i.v. challenge of both M3 and MM3 tumor cells than MM3-bearing mice; this resistance was expressed as lower number of lung metastases and lower tumor-cell proliferation in metastatic nodules. M3 was also able to control the development of spontaneous metastases: metastases developed in all M3-excised mice, compared with none in M3-bearing mice, while MM3-bearing mice also bearing a secondary M3 tumor developed fewer metastases than mice bearing MM3 only. This anti-metastatic effect does not appear to depend on classical immunological mechanisms since no difference could be detected between the 2 tumors in response to T cells, NK, macrophages or antibodies.
Similar articles
-
Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability.Int J Cancer. 1996 Mar 15;65(6):812-20. doi: 10.1002/(SICI)1097-0215(19960315)65:6<812::AID-IJC18>3.0.CO;2-5. Int J Cancer. 1996. PMID: 8631597
-
Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.Cancer Gene Ther. 2000 Jun;7(6):826-38. doi: 10.1038/sj.cgt.7700176. Cancer Gene Ther. 2000. PMID: 10880012
-
Lymphocyte-induced angiogenesis: correlation with the metastatic incidence of two murine mammary adenocarcinomas.Invasion Metastasis. 1986;6(5):313-20. Invasion Metastasis. 1986. PMID: 2430911
-
Tumor necrosis can facilitate the appearance of metastases.Clin Exp Metastasis. 1988 Mar-Apr;6(2):121-9. doi: 10.1007/BF01784843. Clin Exp Metastasis. 1988. PMID: 3345611
-
Levels of plasmatic fibronectin in mice bearing adenocarcinomas of different metastasizing ability.Cancer Lett. 1985 Nov;29(2):189-95. doi: 10.1016/0304-3835(85)90158-2. Cancer Lett. 1985. PMID: 4075288
Cited by
-
A serum-mediated mechanism for concomitant resistance shared by immunogenic and non-immunogenic murine tumours.Br J Cancer. 1996 Jul;74(2):178-86. doi: 10.1038/bjc.1996.335. Br J Cancer. 1996. PMID: 8688319 Free PMC article.
-
Neuroimmune Regulation of Surgery-Associated Metastases.Cells. 2021 Feb 20;10(2):454. doi: 10.3390/cells10020454. Cells. 2021. PMID: 33672617 Free PMC article. Review.
-
Cellular interactions in metastasis.Cancer Metastasis Rev. 1990 Jul;9(1):21-34. doi: 10.1007/BF00047586. Cancer Metastasis Rev. 1990. PMID: 2208566 Review.
-
Inhibitory effects of plasminogen fragment on experimentally induced neovascularization of rat corneas.Graefes Arch Clin Exp Ophthalmol. 1997 Sep;235(9):584-6. doi: 10.1007/BF00947088. Graefes Arch Clin Exp Ophthalmol. 1997. PMID: 9342609
-
Angiogenic and antiangiogenic balance regulates concomitant antitumoral resistance.Clin Exp Metastasis. 2004;21(2):177-83. doi: 10.1023/b:clin.0000024762.32172.13. Clin Exp Metastasis. 2004. PMID: 15168735
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical